Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Casopitant

Generic Name: Casopitant

Drug Type: Small Molecule

Chemical Formula: C_₃₀H_₃₅F_₇N_₄O_₂

CAS Number: 414910-27-3

Unique Ingredient Identifier: 3B03KPM27L

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in urinary incontinence and adverse effects (chemotherapy).

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy

Phase 3

Withdrawn

Posted: 2009/05/01

Sponsor:GlaxoSmithKline

ID:NCT00891761

A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia

Phase 2

Completed

Posted: 2008/04/02

Sponsor:GlaxoSmithKline

ID:NCT00650871

A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Phase 3

Completed

Posted: 2008/01/25

Sponsor:GlaxoSmithKline

ID:NCT00601172

The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects

Phase 1

Completed

Posted: 2007/08/06

Sponsor:GlaxoSmithKline

ID:NCT00511823

A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults

Phase 1

Completed

Posted: 2007/04/16

Sponsor:GlaxoSmithKline

ID:NCT00460707

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy